title: Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia.
abstract: Quercetin has been shown to act as a hyperthermia sensitizer by inhibiting the synthesis of heat shock protein 70 (HSP70) in a variety of tumour cell lines. It is most effective under conditions of low pH. This study was designed to test the hypothesis that quercetin suppresses thermotolerance development in cells adapted to growth at low pH and renders them as responsive as acutely acidified cells to hyperthermia-induced cytotoxicity. Chinese hamster ovarian carcinoma cells (OvCa) were exposed to 42 degrees C hyperthermia and/or quercetin (50-200 mm) at their growth pH of either 7.3 or 6.7 or after acute acidification from 7.3 to 6.7. Thermotolerance development was measured by colony survival. HSP70 synthesis and total protein synthesis were measured by radioactive precursor pulse labelling techniques. Quercetin, in a concentration-dependent manner, reduced the rate of total protein synthesis and increased cytotoxicity equally after acute acidification to pH 6.7 or growth at pH 6.7 at 37 degrees C, and to a greater extent than it did in cells at pH 7.3. At 42 degrees C, 100 mm quercetin inhibited total protein synthesis, HSP70 synthesis and thermotolerance development to a similar extent in cells grown at pH 6.7 or acutely acidified to pH 6.7. In contrast, quercetin reduced but did not completely inhibit HSP70 synthesis and thermotolerance development in cells grown and heated at pH 7.3. These results support the hypothesis that quercetin can specifically reduce thermotolerance development in tumour cells adapted to growth at pHe 6.7 so that they respond similarly to acutely acidified cells. Since many tumours are adapted to growth at low pH and may resist a wide variety of therapeutic modalities, inhibition of thermotolerance expression by quercetin may not only enhance the response to hyperthermia but the response to commonly used therapies such as chemotherapy and radiation.
authors.affiliation: Department of Radiation Oncology, Kimmel Cancer Center and Thomas Jefferson University, Philadelphia, PA 19107, USA. phyllis.wachsberger@mail.tju.edu
authors.forename: P R
authors.initials: PR
authors.lastname: Wachsberger
authors.forename: R
authors.initials: R
authors.lastname: Burd
authors.forename: A
authors.initials: A
authors.lastname: Bhala
authors.forename: S B
authors.initials: SB
authors.lastname: Bobyock
authors.forename: M L
authors.initials: ML
authors.lastname: Wahl
authors.forename: C S
authors.initials: CS
authors.lastname: Owen
authors.forename: S B
authors.initials: SB
authors.lastname: Rifat
authors.forename: D B
authors.initials: DB
authors.lastname: Leeper
mesh_terms: D000143:Acids; D000818:Animals; D016466:CHO Cells; D002470:Cell Survival; D006224:Cricetinae; D005260:Female; D006360:Heat-Shock Proteins / Q000378:metabolism; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D006979:Hyperthermia, Induced; D010051:Ovarian Neoplasms; D011794:Quercetin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
chemical_list: D000143:Acids; D006360:Heat-Shock Proteins; D011794:Quercetin